Onyx Biotec Limited IPO
GMP, Subscription, Price, Dates & Financial Details
Onyx Biotec Limited, originally incorporated as Onyx Biotec Private Limited in 2005, was converted into a public limited company in 2024, adopting its current name. The company operates in the pharmaceutical industry, specializing in the manufacture and supply of sterile pharmaceutical products,…
Open Date
Wed, 13 Nov 2024
Close Date
Mon, 18 Nov 2024
Price Band
₹ 58 – 61
Lot Size
2000
Issue Size
₹ 29.34 Cr
Minimum Investment
₹ 244,000 (4000 Shares)
Grey Market Premium Analysis
Day Wise GMP→Unofficial premium quoted in the grey market, tracked daily against the price band cap.
Grey market trading is unregulated. GMP figures are indicative only and should not be the sole basis for investment decisions - treat as a sentiment indicator, not a guarantee.
IPO Details
Onyx Biotec Limited IPO has successfully completed its IPO process and is now listed on NSE SME Platform. According to the Red Herring Prospectus (RHP), the IPO was a book-built issue with a total issue size of ₹29.34 Crore, comprising a fresh issue of 48.10 Lakh equity shares aggregating to ₹29.34 Crore.
The Onyx Biotec Limited IPO remained open for subscription from November 13, 2024, to November 18, 2024. The basis of allotment was finalized on November 19, 2024, and the company's shares were listed on NSE SME Platform on November 21, 2024.
The company had fixed the price band at ₹58 to ₹61 per share, with a lot size of 2000 shares. Retail investors were required to make a minimum investment of ₹244,000 (based on the upper price band) to apply for one lot.
Mas Services Limited served as the registrar to the issue. acted as the Book Running Lead Managers (BRLMs) to the issue.
With the successful completion of the IPO process, Onyx Biotec Limited is now a publicly listed company on NSE SME Platform. Investors can track the company's share price, trading performance, financial results, and corporate announcements through the stock exchanges.
Onyx Biotec Limited IPO Timeline (Tentative)
- IPO Open Date
- Wed, 13 Nov 24
- IPO Close Date
- Mon, 18 Nov 24
- Basis of Allotment
- Tue, 19 Nov 24
- Initiation of Refunds
- Wed, 20 Nov 24
- Credit of Shares to Demat
- Wed, 20 Nov 24
- Listing Date
- Thu, 21 Nov 24 — NSE & BSE
Open Date
13 November 2024
Close Date
18 November 2024
Basis Of Allotment
19 November 2024
Listing Date
21 November 2024
IPO Subscription
Check Live Subscription →The Onyx Biotec Limited IPO has received bids for 63,38,56,000 shares against 32,00,000 shares offered, resulting in an overall subscription of 198.08x. the NII category is subscribed 603.22x, Retail Investors 118.26x, and QIBs 32.49x.
QIB
32.49x
NII
603.22x
RII
118.26x
Total
198.08x
IPO Reservations
The Retail Individual Investor (RII) category has the highest allocation with 16,00,000 shares, representing 33.26% of the total issue. Qualified Institutional Buyers (QIBs) are allocated 9,12,000 shares (18.96%), while Non-Institutional Investors (NIIs) receive 6,88,000 shares (14.3%).
| Category | Shares Offered | Shares Offered % |
|---|---|---|
| Anchor Investors | 1,366,000 | 28.4% |
| Market Maker | 244,000 | 5.07% |
| Qualified Institutions | 912,000 | 18.96% |
| Non-Institutional | 688,000 | 14.3% |
| Retail Investors | 1,600,000 | 33.26% |
| Total | 4,810,000 | 100% |
Financials Details(₹ in Crores)
| Particular | 31 May 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 7476.57 | 7413.58 | 5872.36 | 3683.84 |
| Revenue | 1054.11 | 5387.43 | 3961.65 | 4498.09 |
| Profit After Tax | 130.77 | 303.16 | 184.46 | 335.29 |
| Net Worth | 2618.64 | 2487.87 | 1820.16 | 1637.59 |
| Reserve & Surplus | 1286.42 | 1155.65 | 1230 | 1047.43 |
| Total Borrowings | 3156.14 | 3078.04 | 2922.83 | 1224.39 |
Financials Performance
Performance Indicators
EPS Pre
Earnings per share before the IPO.
P/E Pre
IPO Offer Price ÷ EPS Pre.
EPS Post
Expected earnings per share after the IPO..
P/E (Post Issue)
IPO Offer Price ÷ EPS Post.
Onyx Biotec Limited KPI Information
| Particular | KPI as of May 31, 2024. |
|---|---|
| ROE % | 3.71 |
| ROCE % | 4.99 |
| RoNW % | 4.99 |
| Pat Margin % | 12.42 |
Peers Comparison
No Peer Comparision Available
About Onyx Biotec Limited
Onyx Biotec Limited, originally incorporated as Onyx Biotec Private Limited in 2005, was converted into a public limited company in 2024, adopting its current name. The company operates in the pharmaceutical industry, specializing in the manufacture and supply of sterile pharmaceutical products, including Sterile Water for Injections, Dry Powder Injections, and Dry Syrup. It also acts as a contract manufacturer for a range of pharmaceutical products for both domestic and international markets.
Core Business and Products:
- Sterile Water for Injections: Onyx Biotec started operations in 2010 with this product and has grown to become a prominent supplier to major pharmaceutical companies in India.
- Dry Powder Injections and Dry Syrups: The company manufactures these products for various pharmaceutical companies and healthcare providers in India and abroad.
- Contract Manufacturing: Onyx provides end-to-end product development and manufacturing solutions, including regulatory filing support for both Indian and global markets.
Manufacturing Facilities: Onyx operates two manufacturing units in Himachal Pradesh:
- Unit I: Located in Ropar, it has a capacity of producing 638,889 units of Sterile Water for Injections per day.
- Unit II: Located in Nalagarh, it has a production capacity of 40,000 units of Dry Powder Injections and 26,667 units of Dry Syrup per day (in a single shift).
Both units are equipped with modern equipment, follow sustainable practices, and are accredited by global regulatory agencies, including WHO-GMP (Good Manufacturing Practices). These facilities undergo regular audits by clients and regulators to ensure adherence to quality standards.
Key Clients: Onyx has established long-term relationships with leading pharmaceutical companies, including:
- Hetero Healthcare Limited
- Mankind Pharma Limited
- Sun Pharmaceutical Industries Limited
- Aristo Pharmaceuticals Private Limited
- Macleods Pharmaceuticals Limited
- Axa Parenterals Limited
- FDC Limited
- Zuventus Healthcare Limited
- Akums Drugs and Pharmaceuticals Limited
- Reliance Life Sciences Limited
Onyx Biotec Limited is a growing player in the pharmaceutical manufacturing sector, known for its high-quality sterile products and strong client relationships. The company is focused on expanding its capabilities through strategic investments in manufacturing upgrades and packaging technology, aiming to strengthen its market position both in India and internationally.
Onyx Biotec Limited IPO Promoters
- Sanjay Jain
- Naresh Kumar
- Fateh Pal Singh
Promoters Holding
Holding Pre Issue
88.60%
Holding Post Issue
0.00%
Onyx Biotec Limited IPO Objective
The Company proposes to utilize the Net Proceeds from the Issue towards the following objects:
- Upgradation of existing manufacturing Unit I to manufacture large volume parentals for intravenous use.
- Setting up a high-speed cartooning packaging line at existing manufacturing Unit II for Dry Powder Injections.
- Prepayment or repayment of all or a portion of certain loans availed by the Company.
- General Corporate Purposes.
Onyx Biotec Limited Address / Contact Details
Onyx Biotec Limited
Bir Plassi Near Sainimajraropar,
Nalagarh Road, District Solan –
174 101, Himachal Pradesh
Phone: +91 172 265 6384
Email: generalinfo@onyxbiotec.com
Website: http://www.onyxbiotec.com
IPO Snapshot
Onyx Biotec Limited IPO Lot Size
The Onyx Biotec Limited IPO has a lot size of 2,000 shares. Retail investors require a minimum investment of ₹1,22,000 by applying for 1 lot (2,000 shares). The maximum application allowed for the retail category is 1 lots (2,000 shares), requiring an investment of ₹1,22,000.
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 2,000 | 122,000.00 |
| Retail (Max) | 1 | 2,000 | 122,000.00 |
| S-HNI (Min) | 2 | 4,000 | 244,000.00 |
Issue Reservation
- Anchor Investors — 28.4%
- Market Maker — 5.07%
- QIB — 18.96%
- NII — 14.3%
- RII — 33.26%
Book Running Lead Managers
IPO Documents & Links
Explore More IPOs
Currently Open
Coming Up Next
Disclaimer: This data is for informational purposes only and does not constitute investment advice.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Onyx Biotec Limited IPO?
Onyx Biotec Limited IPO is a Book-building IPO with a total issue size of ₹29.34 crore. The Onyx Biotec Limited IPO price band is ₹58 to 61 per share. The Onyx Biotec Limited IPO subscription opens on Wed, Nov 13, 2024, and closes on Mon, Nov 18, 2024. The Onyx Biotec Limited IPO will be listed on the NSE. Mas Services Limited is the registrar for the Onyx Biotec Limited IPO.
When will the Onyx Biotec Limited IPO open for subscription?
The Onyx Biotec Limited IPO opens on Wed, Nov 13, 2024 and closes on Mon, Nov 18, 2024
What is Onyx Biotec Limited IPO Price Band?
Onyx Biotec Limited IPO Price Band is ₹58 to 61 per share.
What is Onyx Biotec Limited IPO Lot Size?
Onyx Biotec Limited IPO lot size is 2000 shares, Retail investors need a minimum investment of ₹244000 based on the upper price band
What is the minimum investment for Onyx Biotec Limited IPO?
The minimum investment for Onyx Biotec Limited IPO is ₹244000, based on one lot of 2000 shares at the upper price band of ₹61 per share.
How to apply for Onyx Biotec Limited IPO?
Investors can apply for the Onyx Biotec Limited IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Mon, Nov 18, 2024. The application amount remains blocked until the Onyx Biotec Limited IPO allotment is finalized.
What is Onyx Biotec Limited IPO Issue Size?
Onyx Biotec Limited IPO issue size is ₹29.34 crores.
What is the Onyx Biotec Limited IPO Allotment Date?
Onyx Biotec Limited IPO allotment date is Tue, Nov 19, 2024.
Who is the Onyx Biotec Limited IPO Registrar?
The registrar for Onyx Biotec Limited IPO is Mas Services Limited. Investors can go to Mas Services Limited website to check Onyx Biotec Limited IPO allotment status, refund processing, and other IPO-related information.
What is the Onyx Biotec Limited IPO GMP?
The Onyx Biotec Limited IPO GMP (Grey Market Premium) is ₹5 as of Fri, Nov 22, 2024. Based on the upper price band of ₹61 per share, the estimated Onyx Biotec Limited IPO listing price is ₹66, indicating a potential listing gain of approximately 8.20% over the issue price.
Who is the Onyx Biotec Limited IPO Lead Manager?
The book-running lead managers (BRLMs) for the Onyx Biotec Limited IPO are . The lead managers are responsible for managing the IPO process, including issue structuring, regulatory compliance, marketing the public issue, coordinating with investors, and ensuring a smooth listing process. For complete details, investors should refer to the Onyx Biotec Limited IPO Red Herring Prospectus (RHP).